{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:25:22Z","timestamp":1779233122744,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bonr.2021.100761","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T13:47:01Z","timestamp":1615124821000},"page":"100761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A novel case of neonatal severe hyperparathyroidism successfully treated with a type II calcimimetic drug"],"prefix":"10.1016","volume":"14","author":[{"given":"T.L.","family":"Leunbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.T.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cipliene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.S.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Schou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bonr.2021.100761_bb0005","doi-asserted-by":"crossref","first-page":"354","DOI":"10.11138\/ccmbm\/2017.14.3.354","article-title":"Neonatal severe hyperparathyroidism secondary to a novel homozygous CASR gene mutation","volume":"14","author":"Ahmad","year":"2017","journal-title":"Clin. Cases Mineral Bone Metab."},{"key":"10.1016\/j.bonr.2021.100761_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000380990","article-title":"Physiology of calcium, phosphate, magnesium and vitamin D","volume":"28","author":"Allgrove","year":"2015","journal-title":"Endocr. Dev."},{"key":"10.1016\/j.bonr.2021.100761_bb0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bone.2014.04.010","article-title":"Novel homozygous inactivating mutation of the calcium-sensing receptor gene (CASR) in neonatal severe hyperparathyroidism-lack of effect of cinacalcet","volume":"64","author":"Atay","year":"2014","journal-title":"Bone."},{"issue":"1","key":"10.1016\/j.bonr.2021.100761_bb0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12887-018-1319-0","article-title":"Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation","volume":"18","author":"Capozza","year":"2018","journal-title":"BMC Pediatr."},{"issue":"1","key":"10.1016\/j.bonr.2021.100761_bb0025","first-page":"122","article-title":"Current treatment of hypoparathyroidism: theory versus reality waiting guidelines for children and adolescents","volume":"89","author":"Di Maio","year":"2018","journal-title":"Acta Biomed"},{"key":"10.1016\/j.bonr.2021.100761_bb0030","article-title":"Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients","volume":"2015","author":"Fisher","year":"2015","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"issue":"3","key":"10.1016\/j.bonr.2021.100761_bb0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1515\/jpem-2018-0307","article-title":"Cinacalcet therapy in an infant with an R185Q calcium-sensing receptor mutation causing hyperparathyroidism: a case report and review of the literature","volume":"32","author":"Forman","year":"2019","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bonr.2021.100761_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1210\/jc.2013-2834","article-title":"Cinacalcet monotherapy in neonatal severe hyperparathyroidism: a case study and review","volume":"99","author":"Gannon","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bonr.2021.100761_bb0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000350540","article-title":"Neonatal hypercalcemia due to a homozygous mutation in the calcium-sensing receptor: failure of cinacalcet","volume":"104","author":"Garcia Soblechero","year":"2013","journal-title":"Neonatology"},{"issue":"5","key":"10.1016\/j.bonr.2021.100761_bb0050","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1530\/EJE-16-0223","article-title":"Heterozygous inactivating CaSR mutations causing neonatal hyperparathyroidism: function, inheritance and phenotype","volume":"175","author":"Glaudo","year":"2016","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.bonr.2021.100761_bb0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000510623","article-title":"Cinacalcet as a first-line treatment in neonatal severe hyperparathyroidism secondary to calcium sensing receptor (CaSR) mutation","volume":"93","author":"Gulcan-Kersin","year":"2020","journal-title":"Horm. Res. Paediatr."},{"issue":"12","key":"10.1016\/j.bonr.2021.100761_bb0060","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/hmg\/dds105","article-title":"Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites","volume":"21","author":"Hannan","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.bonr.2021.100761_bb0065","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/JME-16-0124","article-title":"Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis","volume":"57","author":"Hannan","year":"2016","journal-title":"J. Mol. Endocrinol."},{"issue":"21","key":"10.1016\/j.bonr.2021.100761_bb0070","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1111\/bph.14086","article-title":"Calcimimetic and calcilytic therapies for inherited disorders of the calcium-sensing receptor signalling pathway","volume":"175","author":"Hannan","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bonr.2021.100761_bb0075","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1210\/jc.2008-2484","article-title":"A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia","volume":"94","author":"Lietman","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bonr.2021.100761_bb0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejmg.2016.02.001","article-title":"Neonatal severe hyperparathyroidism caused by homozygous mutation in CASR: a rare cause of life-threatening hypercalcemia","volume":"59","author":"Murphy","year":"2016","journal-title":"Eur. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.bonr.2021.100761_bb0085","doi-asserted-by":"crossref","first-page":"E707","DOI":"10.1210\/jc.2010-1306","article-title":"Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet","volume":"96","author":"Reh","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.bonr.2021.100761_bb0090","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1515\/jpem-2015-0261","article-title":"Treatment experience and long-term follow-up data in two severe neonatal hyperparathyroidism cases","volume":"29","author":"Savas-Erdeve","year":"2016","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bonr.2021.100761_bb0095","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/jbmr.3296","article-title":"Hypercalcemic disorders in children","volume":"32","author":"Stokes","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"45","key":"10.1016\/j.bonr.2021.100761_bb0100","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013128","article-title":"Novel homozygous inactivating mutation of the calcium-sensing receptor gene in neonatal severe hyperparathyroidism responding to cinacalcet therapy: a case report and literature review","volume":"97","author":"Sun","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.bonr.2021.100761_bb0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13023-017-0570-z","article-title":"Diseases associated with calcium-sensing receptor","volume":"12","author":"Vahe","year":"2017","journal-title":"Orphanet. J. Rare Dis."},{"issue":"3","key":"10.1016\/j.bonr.2021.100761_bb0110","doi-asserted-by":"crossref","first-page":"e812","DOI":"10.1542\/peds.2011-0128","article-title":"Successful use of bisphosphonate and calcimimetic in neonatal severe primary hyperparathyroidism","volume":"129","author":"Wilhelm-Bals","year":"2012","journal-title":"Pediatrics."}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187221000164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187221000164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:26:12Z","timestamp":1762446372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187221000164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":22,"alternative-id":["S2352187221000164"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2021.100761","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel case of neonatal severe hyperparathyroidism successfully treated with a type II calcimimetic drug","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2021.100761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100761"}}